Showing 8181-8190 of 8647 results for "".
- The Vision Council Files Joint Letter in Opposition of China 301 Tariffs, Will Testify on Thursdayhttps://modernod.com/news/the-vision-council-files-joint-letter-in-opposition-of-china-301-tariffs-will-testify-on-thursday/2476669/This weekend, The Vision Council, the American Academy of Ophthalmology, National Association of Opticians and Optometrists, Opticians Association of America, National Association of Vision Care Plans, Prevent Blindness, and OneSight jointly filed a letter to the United States Trade Representativ
- New Survey Highlights Growing Insurance Problem That Delays Sight-Saving Carehttps://modernod.com/news/new-survey-highlights-growing-insurance-problem-that-delays-sight-saving-care/2476670/The majority of ophthalmologists in a new survey said that a cost-management tool required by health insurance companies is delaying or disrupting the sight-saving care they give their patients. The tool is called prior authorization. Insurance companies use it to control costs by reducing medica
- UK’s First TransForm Inlay Procedure Performed by Sheraz Daya, MDhttps://modernod.com/news/uks-first-transform-inlay-procedure-performed-by-sheraz-daya-md/2476668/The first patients in the UK have undergone the TransForm Corneal Allograft (TCA) procedure, which was performed by Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth. TCA is a new procedur
- Harrow Health to Locate Headquarters in Nashville, Tennesseehttps://modernod.com/news/harrow-health-to-locate-headquarters-in-nashville-tennessee/2476667/Harrow Health announced that the company will relocate its headquarters from San Diego to Nashville, Tennessee. “From our new home in Nashville, our team will continue to start, finance and grow pharmaceutical companies that will develop innovative, affordable and accessible medicines to s
- Be The Match BioTherapies and TrakCel Partner to Standardize Cell and Gene Therapy Supply Chain Solutionshttps://modernod.com/news/be-the-match-biotherapies-and-trakcel-partner-to-standardize-cell-and-gene-therapy-supply-chain-solutions/2476662/Be The Match BioTherapies and TrakCel, a software developer for cell and gene therapy supply chain tracking and orchestration systems, announced a collaboration that will provide integrated solutions for companies develo
- Santen Publishes New Data in Glaucoma and Dry Eye Drug Candidateshttps://modernod.com/news/santen-publishes-new-data-in-glaucoma-and-dry-eye-drug-candidates/2476660/Santen EMEA shared the preliminary results of its two real world evidence (RWE) studies, VISIONARY and PERSPECTIVE, at this year’s European Society of Ophthalmology (SOE) congress. The studies assessed the impact of the effectiveness, tolerability, and safety of topical preservative-free taflupro
- House Subcommittee Urges FTC to Modernize Contact Lens Verification Processhttps://modernod.com/news/house-subcommittee-urges-ftc-to-modernize-contact-lens-verification-process/2476657/The Health Care Alliance for Patient Safety expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified, according to a news
- First Subject Enrolled in Trial to Confirm Safety and Efficacy of TearCare Device for Dry Eyehttps://modernod.com/news/first-subject-enrolled-in-large-trial-to-confirm-safety-and-efficacy-of-dry-eye-treatment-device-tearcare/2476650/Sight Sciences announced the first subject has been enrolled in OLYMPIA, a US pivotal trial to further assess the safety and efficacy of TearCare for patients with dry eye disease. TearCare is a wearable, personalized, open-eye technology that delivers regu
- A Single Course of Provention’s PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least 2 Yearshttps://modernod.com/news/a-single-course-of-proventions-prv-031-teplizumab-delays-type-1-diabetes-onset-in-high-risk-individuals-by-at-least-2-years/2476644/Provention Bio announced that results from the National Institutes of Health (NIH)-sponsored “At-Risk” Study were published on-line in The New England Journal of Medicine and presented at the Scientific Sessions of the 79th Annual American Diabetes Association (ADA) meeting.
- Our Tears Could One Day Tell Us If We Have Glaucomahttps://modernod.com/news/our-tears-could-one-day-tell-us-if-we-have-glaucoma/2476643/Contrary to what many think, high pressure inside the eye does not define glaucoma and investigators want to know if the proteins circulating in the fluid of our eyes might, according to researchers at the Medical College of Georgia at Augusta University. While some patients do have classi